The Control of the Antibody Isotype Response to Recombinant Human Immunodeficiency Virus gp120 Antigen by Adjuvants
- 1 October 1992
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 8 (10), 1765-1771
- https://doi.org/10.1089/aid.1992.8.1765
Abstract
Both saponin and muramyl dipeptide (MDP) formulated with a squalane-in-water emulsion of large particle size prepared with a vortex mixer were superior to Al(OH)3 as adjuvants for HIV gp120 in mice. All the adjuvants induced IgG1 antibody, but saponin elicited the highest titers of IgG2a. The secretion of interleukin-5 (IL-5) and interferonγ (IFNγ) by lymph node cells cultured in vitro with gp120 was studied. All the cultures secreted IL-5, but only those from saponin-immunized mice produced IFNγ, suggesting that saponin is capable of activating both the Th1 and TH2 T-cell subsets. The titers of neutralizing antibodies were low with both MDP and saponin, and they occurred in mice which were also positive for antibodies against a V3 loop peptide. Glucosaminylmuramyl dipeptide (GMDP) which is less pyrogenic than MDP and a nonpyrogenic analog GMDPA, displayed equivalent adjuvant activity to MDP. The level and isotype composition of antibodies induced by GMDP in combination with squalane emulsions depended on the dimension of the emulsion particles. With a large (2500 nm) particle size the response was confined to IgG1 in Balb/c mice, but when this was reduced to 150 nm by sonication the antibody response was increased and relatively high levels of IgG2a appeared in some mice.Keywords
This publication has 21 references indexed in Scilit:
- Human TH1 and TH2 subsets: doubt no moreImmunology Today, 1991
- Studies on the immunogenicity of chinese hamster ovary cell-derived recombinant gp120 (HIV-1IIIB)Vaccine, 1991
- Cytokines and lg switching: evolutionary divergence between mice and humansImmunology Today, 1990
- Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccineThe Lancet, 1990
- Induction of CD4 + Human Cytolytic T Cells Specific for HIV-Infected Cells by a Gp160 Subunit VaccineScience, 1990
- A Formalin-Inactivated Whole SIV Vaccine Confers Protection in MacaquesScience, 1989
- Evaluation of Human and Simian Immunodeficiency Virus Plaque and Neutralization AssaysJournal of General Virology, 1989
- An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1AIDS, 1989
- The Serum Antibody Response Distributed in Subclasses and Isotypes after Intranasal and Subcutaneous Immunization with Influenza Virus Immunostimulating ComplexesScandinavian Journal of Immunology, 1988
- Adjuvant Requirements for Protective Immunization of Mice Using a Trypanosoma cruzi 90K Cell Surface GlycoproteinInternational Archives of Allergy and Immunology, 1984